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ABSTRACT
Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxy-
benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium] is an alkaloid
present in plant extracts and has a history of use in traditional
Chinese and Native American medicine. Because of its ability to
arrest the cell cycle and cause apoptosis of several malignant cell
lines, it has received attention as a potential anticancer therapeutic
agent. Previous studies suggest that mitochondria may be an
important target of berberine, but relatively little is known about
the extent or molecular mechanisms of berberine-mitochondrial
interactions. The objective of the present work was to investigate
the interaction of berberine with mitochondria, both in situ and in
isolated mitochondrial fractions. The data show that berberine is
selectively accumulated by mitochondria, which is accompanied
by arrest of cell proliferation, mitochondrial fragmentation and
depolarization, oxidative stress, and a decrease in ATP levels.
Electron microscopy of berberine-treated cells shows a reduction
in mitochondria-like structures, accompanied by a decrease in
mitochondrial DNA copy number. Isolated mitochondrial fractions
treated with berberine had slower mitochondrial respiration, es-
pecially when complex I substrates were used, and increased
complex I-dependent oxidative stress. It is also demonstrated for
the first time that berberine stimulates the mitochondrial perme-
ability transition. Direct effects on ATPase activity were not de-
tected. The present work demonstrates a number of previously
unknown alterations of mitochondrial physiology induced by ber-
berine, a potential chemotherapeutic agent, although it also sug-
gests that high doses of berberine should not be used without a
proper toxicology assessment.
Berberine (Fig. 1) is an isoquinoline alkaloid, usually ex-
tracted from rhizomes and roots from plants such as the
Berbis, Coptis, and Hydrastis species. Such herbs have long
been used in traditional Chinese and Native American med-
icine for the treatment of several maladies. Several pharma-
cologic properties have been attributed to berberine, includ-
ing anti-inflammatory (Kuo et al., 2004), antimicrobial
(Stermitz et al., 2000), antidiarrheal (Rabbani et al., 1987),
antiproliferative (Letasiova et al., 2006), antioxidative
(Shirwaikar et al., 2006), and vasorelaxant (Ko et al., 2000)
actions. Different types of effects such as up-regulation of
cyclooxygenase-2 (Fukuda et al., 1999) and hypoxia-inducible
factor-1 (Lin et al., 2004) expression, modulation of multidrug
resistance protein expression (Lin et al., 1999), reduction of
amyloid- peptide levels (Asai et al., 2007), formation of DNA
adducts (Kuo et al., 1995), and cell cycle arrest (Lin et al.,
2006; Mantena et al., 2006b) were also previously reported.
The antiproliferative properties of berberine raise the in-
teresting possibility that the compound may be useful for
anticancer therapeutics, and in fact, berberine has been
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shown to promote cell death in several transformed cell lines
(Hwang et al., 2006; Lee et al., 2006; Letasiova et al., 2006;
Lin et al., 2006; Mantena et al., 2006b). Apoptosis induced by
berberine involves activation of caspases (Mantena et al.,
2006b), increased Bax expression (Lin et al., 2006; Hwang et
al., 2006; Lin et al., 2006; Mantena et al., 2006b), DNA
fragmentation (Kuo et al., 1995; Hwang et al., 2006; Leta-
siova et al., 2006; Mantena et al., 2006b), and cytochrome c
release (Hwang et al., 2006; Lin et al., 2006), suggesting a
possible role of mitochondria in the process (Mantena et al.,
2006a; Jantova et al., 2007). Mitochondria could be involved
via release of cytochrome c, which can occur through Bax
interaction with mitochondrial membranes, as well as
through the formation of the mitochondrial permeability
transition (MPT) pore (Bouchier-Hayes et al., 2005). The
MPT pore can be defined as a voltage-dependent, cyclosporin
A (CsA)-sensitive, high-conductance channel of the inner mi-
tochondrial membrane. Under the experimental conditions
used in most in vitro studies, the MPT is accompanied by
mitochondrial depolarization, respiratory inhibition or stim-
ulation, matrix swelling, matrix pyridine nucleotide deple-
tion, and release of intermembrane proteins, including cyto-
chrome c (Bernardi et al., 2006).
Apoptosis is an active process that requires cell energy for
its execution. The cellular energy pool has an important role
determining if cells die by apoptosis or necrosis (Kirveliene et
al., 2003). In addition, the cell cycle also requires energy.
Cyclin-dependent kinase-cyclin complexes ensure orderly
passage through the cell cycle by the appropriate temporal
phosphorylation of specific target proteins. When the cellular
energy pool is lower, such target proteins are dephosphory-
lated, and cell cycle arrest occurs (Gemin et al., 2005). Mito-
chondrial generation of ATP can therefore be considered a
significant control mechanism that helps govern both cell
cycle progression and programmed cell death. Consequently,
mitochondria hold a great promise as targets for therapeutic
intervention.
For the present work, mouse melanoma K1735-M2 cells, a
highly invasive melanoma cell line (Helige et al., 1993), were
used to investigate berberine effects on cell proliferation and
in situ mitochondrial physiology. In addition, isolated mito-
chondrial fractions were used to investigate direct berberine
effects. We verified that berberine is accumulated by mito-
chondria in K1735-M2 mouse melanoma cells, causing mito-
chondrial fragmentation, depolarization, and oxidative
stress. Results obtained in isolated mitochondrial fractions
confirmed induction of oxidative stress by berberine with
complex I substrates. In addition, the present work describes
an overall inhibition of mitochondrial respiration that ap-
pears more extensive when complex I substrates are used. It
is demonstrated for the first time that berberine also en-
hances the calcium-induced MPT.
Materials and Methods
Materials
Berberine hemisulfate was obtained from Sigma-Aldrich (St.
Louis, MO) and prepared in dimethyl sulfoxide (DMSO). The total
volume of DMSO was always lower than 0.1%, which had negligible
effects in all experiments. Nevertheless, total volume was always
lower than 0.1%. Tetramethyl rhodamine methyl ester (TMRM),
Hoechst 33342, and Calcein-AM were obtained from Molecular
Probes (Carlsbad, CA). All other compounds were of the highest
grade of purity commercially available.
Animals
Male Wistar rats (10 weeks old), housed at 22  2°C under artificial
light for a 12-h light/day cycle and with access to water and food ad
libitum, were used throughout the experiments. The research proce-
dure was carried out in accordance with the European Requirement for
Vertebrate Animal Research and with the internal Standards for
Animal Research at the Center for Neurosciences and Cell Biology.
Cell Culture
K1735-M2 mouse melanoma cells (kindly offered by Dr. Lillian
Repesh, Department of Anatomy, Microbiology, and Pathology, Uni-
versity of Minnesota School of Medicine, Duluth, MN) were cultured
in Dulbecco’s modified Eagle’s medium (GIBCO, Grand Island, NY)
with 10% Fetal Clone III (FC3; HyClone, Logan, UT) in an atmo-
sphere of 5% CO2 at 37°C.
Assessment of Cell Proliferation
Sulforhodamine B assays were conducted to measure the effects of
berberine on the proliferation of K1735-M2 cells, as described by
Papazisis et al. (1997). Cells were seeded at a concentration of 1 
105 cells/ml in 24-well plates and allowed to recover for 1 day before
drug addition. One of the wells was dried and washed once with
phosphate-buffered saline to be used as a measure of cell mass at
time 0. Berberine at various concentrations (0, 10, 25, 50, 75, and 100
M) was incubated with K1735-M2 cells for 24, 48, 72, and 96 h,
times at which the plates were collected. After cell fixation and
sulforhodamine labeling, absorbance was measured in a spectropho-
tometer at 540 nm; the amount of dye released is proportional to the
number of cells present in the dish and is a reliable indicator of cell
proliferation.
Confocal and Epifluorescence Imaging of K1735-M2 Cells
Cells were seeded in glass-bottom dishes (P35G-1.5-14-C; Matek
Corporation, Ashland, MA) at a concentration of 1 to 2 104 cells/ml.
Cells were allowed to attach for 24 h and then treated with berberine
or with solvent (DMSO) for the desired time.
Detection of Berberine Mitochondrial Accumulation. Ber-
berine is a fluorescent compound, and its localization in cells was
visualized using a Nikon Eclipse TE2000U epifluorescence micro-
scope and a fluorescein filter set (Nikon, Melville, NY). Hoechst
33342 (2 g/ml) was added to cells 30 min before the end of the
berberine exposure time. FCCP (10 M) was preincubated with one
set of cells treated with berberine to investigate whether dissipation
of mitochondrial membrane potential alters berberine accumulation.
Fig. 1. Chemical structure of berberine.
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Labeling with Hoechst 33342, TMRM, and Calcein-AM. Be-
fore the ending of drug exposure time, cells in glass-bottom dishes
were incubated with TMRM (100 nM), Hoechst 33342 (1 g/ml), and
calcein-AM (300 nM) for 30 min at 37°C in the dark. Due to the very
low fluorescence of the probes in the extracellular media, the images
were collected without replacing the cell culture media. The images
were obtained using a Nikon C-1 laser scanning confocal microscope.
TMRM signal was acquired using a green He-Ne laser. The cal-
cein-AM signal was acquired using an air-cooled argon laser, and the
Hoechst signal was obtained by using a violet diode laser. Differ-
ential interference contrast images using the confocal microscope
were collected using the air-cooled argon laser and the appropri-
ate detector.
Quantification of TMRMMitochondrial Fluorescence. Cells
were seeded, treated with TMRM as described above, and visualized
with a Nikon Eclipse TE2000U epifluorescence microscope. Using
Metamorph software (Universal Imaging, Downingtown, PA), cells
were analyzed in terms of their mean TMRM fluorescence values and
also in terms of the S.D. values for the fluorescence of each cell. The
S.D. values were used to characterize the effects of berberine of
mitochondrial TMRM florescence because they give a more precise
idea of the magnitude of the difference between cytosolic and mito-
chondrial TMRM accumulation.
Electron Microscopy of K1735-M2 Cells
After treatment, trypsinized cells were fixed for electron micros-
copy by adding 3% glutaraldehyde in 0.1 M sodium cacodylate buffer,
pH 7.3, and were incubated for 2 h at 4°C. After centrifugation
(2500g, 3 min), pellets were washed with 0.1 M sodium cacodylate
buffer, pH 7.3, and resuspended in 1% OsO4 buffered with 0.1 M
sodium cacodylate, pH 7.3. After a 2-h incubation, pellets were
washed with cacodylate buffer, pH 7.3, and embedded in 1% agar.
Samples were then dehydrated in ethanol and embedded in Spurr’s
resin. Ultrathin sections were obtained with an LKB ultra-mi-
crotome Ultrotome III (GE Healthcare, Little Chalfont, Bucking-
hamshire, UK), stained with methanolic uranyl acetate followed by
lead citrate, and examined with a JEOL Jem-100SX electron micro-
scope (JEOL, Tokyo, Japan) operated at 80 kV. Five to 10 micro-
graphs were taken from random fields, and mitochondrial profiles
were observed. Each field contained one to two cells. By definition,
mitochondrial bodies are structures that possessed morphological
features of mitochondria, including a double-membrane system and
inner cristae.
Determination of Mitochondrial DNA Copy Number
Total genomic nuclear and mtDNA from M2 cells was isolated
using the GenElute Mammalian Genomic DNA Miniprep Kit
(Sigma-Aldrich). Standard curves were generated from the control
DNA sample using serial dilutions. Quantitative real-time PCR us-
ing the LightCycler system (Roche Diagnostics, Indianapolis, IN)
was performed, and the following reaction components were pre-
pared: 3.6 l of water, 0.2 l of forward primer (0.2 M), 0.2 l of
reverse primer (0.2 M), and 5.0 l of LightCyler (Roche Diagnos-
tics). LightCycler mixture (9 l) was filled in the LightCycler glass
capillaries, and 1 l of DNA sample (2 ng) was added as PCR
template. 5COI and 3COI are mtDNA primers (Thundathil et al.,
2005), and MuRTGADD45a (5-ACCCCGATAACGTGGTACTG-3)
and MuGADD45R (5-TGACCCGCAGGATGTTGATG-3) are mouse
GADD45 genomic DNA primers that sit in exon 3. Capillaries were
closed, centrifuged, and placed into the LightCycler rotor. The fol-
lowing LightCycler experimental run protocol was used: denatur-
ation program (95°C for 30 s), amplification and quantification pro-
gram repeated 50 times (95°C for 5 s, 60°C for 20 s, 72°C for 20 s),
melting curve program (95–45-95°C with a final heating rate of
0.1°C/s and a continuous fluorescence measurement), and finally a
cooling step to 40°C. The crossing points for each transcript based on
the standard curves were mathematically determined.
Determination of Oxidative Stress in Live Cells
Vital imaging of oxidative stress in K1735-M2 was determined
according to the protocol described by Sarda˜o et al. (2007). Cells
seeded in glass-bottom dishes were incubated with CM-H2DCFDA
(7.5 M) for 1 h at 37°C in the dark. Media were then replaced by
new prewarmed DMEM, and then cells were returned to the incu-
bator for another hour. Media were then again replaced by 2 ml of
Krebs buffer (1 mM CaCl2, 132 mM NaCl, 4 mM KCl, 1.2 mM
Na2HPO4, 1.4 mM MgCl2, 6 mM glucose, 10 mM HEPES, pH 7.4).
Cells were observed by epifluorescence microscopy using a Nikon
Eclipse TE2000U microscope (fluorescein filter), and images were
obtained using Metamorph software (Universal Imaging).
Adenine Nucleotide Extraction from Cells in Culture
An acid extraction procedure was used to evaluate the intracellu-
lar concentration of adenine nucleotides. Both adherent and nonad-
herent (dead) cells were collected. Adenine nucleotides were sepa-
rated by reverse-phase high-performance liquid chromatography.
The chromatographic apparatus was a Beckman-System Gold (Beck-
man Coulter, Fullerton, CA), consisting of a 126 Binary Pump Model
and a 166 Variable UV detector, computer-controlled. The detection
wavelength was 254 nm, and the column was a Lichrospher
100RP-18 (5 m) from Merck (Dramstadt, Germany). An isocratic
elution with 100 mM phosphate buffer (KH2PO4), pH 6.5, and 1%
methanol was performed with a flow rate of 1.1 ml/min. The required
time for each analysis was 5 min. Quantification was achieved by
employing ATP, ADP, and AMP standard curves.
Isolation of Rat Liver Mitochondria
Mitochondria were isolated from liver of male Wistar rats by
conventional methods with slight modifications. Homogenization
medium contained 250 mM sucrose, 10 mM HEPES, pH 7.4, 1 mM
EGTA, and 0.1% fat-free bovine serum albumin (BSA). EGTA and
BSA were omitted from the final washing medium, adjusted at pH
7.2. The mitochondrial pellet was washed twice, suspended in the
washing medium, and immediately used. Protein content was deter-
mined by the biuret method (Gornall et al., 1949) calibrated
with BSA.
Oxygen Consumption
Oxygen consumption of isolated liver mitochondria was polaro-
graphically monitored with a Clark oxygen electrode connected to a
suitable recorder in a 1-ml thermostated, water-jacketed, closed
chamber with magnetic stirring at a constant temperature of 30°C.
The standard respiratory medium consisted of 135 mM sucrose, 65
mM KCl, 2.5 mM MgCl2, 5 mM KH2PO4, and 5 mM HEPES, pH 7.2.
Mitochondria were suspended at a concentration of 1.5 mg/ml in the
respiratory medium. Respiration was started by adding 5 mM glu-
tamate plus malate or 5 mM succinate with 3 M rotenone. ADP (125
nmol) was added to initiate state 3 respiration. Oligomycin (1 g)
and FCCP (1 M) were also added to the system to inhibit passive
proton flux through the ATP synthase and to uncouple respiration,
respectively. Berberine was preincubated with mitochondria in the
reaction medium for 2 min before the addition of the respiratory
substrate.
Mitochondrial Transmembrane Potential
The mitochondrial transmembrane potential () was indirectly
estimated by the mitochondrial accumulation of the lipophilic cation
tetraphenylphosphonium cation (TPP) as detected by using a
TPP-selective electrode in combination with an Ag/AgCl-saturated
reference electrode. Both the TPP electrode and the reference elec-
trode were inserted into an open vessel with magnetic stirring and
were connected to a pH meter (model 3305; Jenway, Essex, UK). The
signals were fed to a potentiometric recorder (model BD 121; Kipp &
Zonen B.V., Delft, The Netherlands). No correction was made for the
“passive” binding of TPP to the mitochondrial membranes since the
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purpose of the experiments was to show relative changes in poten-
tials rather than absolute values. Mitochondrial protein (1.5 mg) was
suspended under constant stirring in 1 ml of reaction medium com-
posed of 125 mM sucrose, 65 mM KCl, 5 mM KH2PO4, 2.5 mM
MgCl2, and 5 mM HEPES, pH 7.4 (30°C), supplemented with 3 M
TPP. Mitochondria were energized with 10 mM glutamate/malate
or 10 mM succinate plus 3 M rotenone. Berberine was added before
mitochondrial protein. ADP (125 nmol) was added to initiate phos-
phorylation. Absolute values for membrane potential (in millivolts)
were determined from the equation originally proposed by Kamo et
al. (1979), assuming Nernst distribution of the ion across the mem-
brane electrode. A matrix volume of 1.1 l/mg protein was assumed.
Mitochondrial Swelling
Mitochondrial osmotic volume changes were followed by the de-
crease of absorbance at 540 nm with a Jasco V-560 spectrophotom-
eter (Jasco, Tokyo, Japan). The assays were performed in 2 ml of the
reaction media (200 mM sucrose, 10 mM Tris-MOPS, pH 7.4, 10 M
EGTA, 1 mM KH2PO4, 1.5 M rotenone, and 2.5 mM succinate), 1.5
mg of protein with constant stirring, at 30°C. Calcium (20 M) was
added to the preparation 1 min after to the start of the experiment.
Cyclosporin A (1 M) was added to the mitochondrial preparation
before the addition of calcium to inhibit the mitochondrial perme-
ability transition. Berberine was preincubated with the mitochon-
drial preparation for 2 min.
Mitochondrial Calcium Loading
Extramitochondrial free Ca2 was assayed by using the hexapo-
tassium salt of the fluorescence probe Calcium Green 5-N (100 nM)
(Rajdev and Reynolds, 1993). In brief, heart mitochondria (0.4 mg)
were suspended in 2 ml of buffer containing 200 mM sucrose, 10 mM
Tris, 10 M EGTA (to complex basal calcium), 1 mM KH2PO4, 2 M
rotenone, and 4 mM succinate. Fluorescence was continuously re-
corded in a water-jacketed cuvette holder at 30°C using a
PerkinElmer LS-55 fluorescence spectrometer (PerkinElmer Life
and Analytical Sciences, Boston, MA) with excitation and emission
wavelengths of 506 and 531 nm, respectively. Slits used were 5 nm
for both excitation and emission wavelengths.
Measurements of Mitochondrial Reactive Oxygen Species
Production
Intramitochondrial oxidative stress was assessed by using the
probe CM-H2DCFDA. Isolated mitochondria were incubated with
CM-H2DCFDA (4 nmol/mg protein) for 30 min under constant circu-
lar motion. Mitochondria were then centrifuged (8000g at 4°C) and
suspended in 1 ml of an ice-cold isolation medium containing 250
mM sucrose and 10 mM HEPES-KOH, pH 7.4. Subsequently, mito-
chondria (1 mg) were suspended in standard reaction media and
supplemented with glutamate/malate (2 mM) and with the different
berberine concentrations tested. Rotenone (1.5 M) and succinate
(2.5 mM) were added during different time points. DCF fluorescence
was continuously recorded in a water-jacketed cuvette holder at 30°C
using a PerkinElmer LS-50B fluorescence spectrometer with excita-
tion and emission wavelengths of 485 and 520 nm (5-nm slits),
respectively.
Mitochondrial ATPase Activity
The effect of berberine on mitochondrial ATPase was observed by
two distinct methods. First, the activity of mitochondrial ATPase
was evaluated thorough detection of pH changes occurring during
ATP hydrolysis, as described previously (Carvalho et al., 1974).
Mitochondria (1.5 mg of protein) were incubated in 1 ml of reaction
media (135 mM sucrose, 65 mM KCL, 2.5 mM MgCl2, 5 mM
KH2PO4), pH 7.2. Reaction was initiated by the addition of 3 mM
ATP. Oligomycin was used as a selective inhibitor of ATPase (FO
unit) and completely abolished pH alterations. Known concentra-
tions of KOH were used to calibrate the system.
ATPase activity was also measured by the ATP-induced genera-
tion of transmembrane potential () by using a TPP-selective
electrode. Mitochondria (1.5 of mg protein) were incubated in 1 ml of
reaction media (125 mM sucrose, 65 mM KCL, 2.5 mMMgCl2, 5 mM
KH2PO4, 5 mM HEPES), pH 7.4 at 30°C. The media were supple-
mented with 3 MTPP and 3 M rotenone. Reaction was started by
3 M ATP. Oligomycin was used as a selective inhibitor of ATP
synthase (FO unit).
Statistical Analysis
Data are expressed as means  S.E.M. and evaluated by one-way
analysis of variance followed by Bonferroni multiple comparison
tests. Differences were considered significant if the p value was lower
than 0.05.
Results
Effect of Berberine in K1735-M2 Cell Line Prolifera-
tion. To investigate whether berberine inhibits cell prolifer-
ation, K1735-M2 mouse melanoma cells were incubated in
the absence and presence of increasing concentrations of
drug (5, 10, 25, 75, and 100 M) for 24, 48, 72, and 96 h. As
shown in Fig. 2, berberine has a dose-time-dependent effect-
inhibiting cell proliferation. Within 24 h of drug treatment,
cell proliferation does not seem to be affected. However, after
48 h of incubation time, the growth profile changes, and an
inhibitory effect is observed for all drug concentrations
tested. Approximately 50% of growth inhibition is observed
for 72 and 96 h of drug exposure. Berberine effect on cell
proliferation is more dependent on time exposure than on the
drug concentration because for 96 h of drug exposure, the
majority of drug concentrations inhibit cell proliferation. As
described elsewhere, the present technique cannot conclude
whether the effect of berberine is due to an increase of cell
death or due to cell cycle arrest.
Berberine Accumulates in Mitochondria of K1735-M2
Cells. To evaluate the intracellular location of berberine accu-
mulation, K1735-M2 cells were incubated with one selected
berberine concentration (25 M) during 6 h and then examined
by epifluorescence microscopy. In Fig. 3A, clusters of green
Fig. 2. Antiproliferative effect of berberine in K1735-M2 mouse mela-
noma cell proliferation profile. Cells (1.0  105) were incubated and
drugged 24 h later with a range of concentrations up to 100 Mduring 24,
48, 72, and 96 h. Cell proliferation was accessed at each time by the SRB
colorimetric assay as described underMaterials and Methods and plotted
against time of exposure and concentration of berberine. Data presented
as means  S.E.M. of four different experiments.
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fluorescence in the cell cytoplasm are observed demonstrating
intracellular berberine accumulation. A magnification of some
of the cells (Fig. 3, C and F) shows that the clusters resemble
mitochondria. To confirm berberine localization, an indirect
method using FCCP, a mitochondrial uncoupler, was chosen
since colocalization with other mitochondrial probes (viz.
TMRM or Mitotracker Red) interfered with berberine localiza-
tion and self-fluorescence (data not shown). When FCCP was
used to dissipate the mitochondrial electric potential, the re-
sults demonstrated that no mitochondrial berberine accumula-
tion could be detected in the presence of FCCP (Fig. 3D). The
observation confirms that berberine is accumulated electro-
phoretically, i.e., with a dependence on themitochondrial trans-
membrane electric potential. Interestingly, whenmitochondrial
membrane potential was collapsed with FCCP, nuclear berber-
ine fluorescence occurs (Fig. 3E), which suggests that in the
absence of an electric gradient, berberine can be accumulated in
the nuclei.
Berberine Causes Mitochondrial Damage on
K1735-M2 Melanoma Cells. To investigate alterations of
mitochondrial morphology induced by berberine, cells were
treated with berberine (5–50 M) for 6 and 24 h (Fig. 4).
Forty-five minutes before the end of the incubation period,
cells were incubated with TMRM. Larger concentrations
were not tested due to the strong interference of berberine
self-fluorescence. It was observable that alterations in mito-
chondrial membrane potential (decreased mitochondrial
TMRM signal) and morphology (mitochondrial fragmenta-
tion) are already observed for 6 h (25 and 50 M). For 24 h,
the effects are greatly enhanced, and alterations appear al-
ready for 10 M berberine. Measurements up to 96 h were
already performed using the same protocol. For such long
time points, a complete dissipation of TMRM signal was
observed in most cells (data not shown). Only a few cells
showed small round (instead of filamentous) mitochondria
still retaining TMRM (data not shown).
To explore in detail mitochondrial alterations caused by
berberine, we mostly focused in one berberine concentration
(25 M) because the objective was to cause notorious mito-
chondrial damage with concentrations not lacking relevance
Fig. 3. Berberine accumulation in mi-
tochondria of K1735-M2 mouse mela-
noma cells after 6 h of drug exposure
evaluated by epifluorescence micros-
copy. Berberine presents green fluo-
rescence, which allows identification
of the intracellular site of drug accu-
mulation. A, accumulation of 25 M
berberine in control cells (berberine
self-fluorescence). B, Hoechst 33342
labeling of field shown in A. C, magni-
fication of some of the cells in A. D, no
berberine signal is observable when
cells were preincubated with 10 M
FCCP, a mitochondrial uncoupler. E,
Hoechst 33342 labeling of field shown
in D. F, magnification of some cells
shown in D. Cells were observed with
an epifluorescence microscope by us-
ing the fluorescein isothiocyanate fil-
ter. Nuclei were labeled with Hoechst
33342. Bar, 30 m.
Fig. 4. Dose-dependent effects of berberine on mitochon-
drial TMRM accumulation and overall morphology. Cells
were incubated with crescent concentrations (numbers on
the left, in micromolar) of berberine for 6 and 24 h. Forty-
five minutes before the end of the incubation time, cells
were incubated with the mitochondrial fluorometric probe
TMRM, which accumulates according to the mitochondrial
electric membrane potential. The most noticeable alter-
ations, which appear dependent on the incubation time and
berberine concentration, are loss of mitochondrial TMRM
accumulation (reflecting mitochondrial depolarization) and
breakage of mitochondrial filamentous. White bar, 15 m.
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in in vivo systems. Cells incubated with berberine were fluo-
rescently labeled with Hoechst 33342 and TMRM. Mitochon-
drial accumulation of TMRM results in red fluorescence.
Because berberine also presents red fluorescence, a conflict
between both signals could be a problem. However, TMRM
has a higher fluorescence quantum yield, so the contribution
of berberine fluorescence is nonsignificant. Figure 5, A and B,
show that after 24 h of treatment, the filamentous mitochon-
drial network is dismantled, and mitochondria appear to be
smaller and rounder in shape. Alterations in mitochondrial
structure occur with intact cell viability, as observed by in-
tracellular calcein-AM accumulation and TMRM fluores-
cence (Fig. 5C). Mitochondrial fragmentation did not increase
the apparent number of mitochondrial bodies as observed by
electron microscopy (EM). In fact, by visualizing several
fields from each treatment group, a lower number of mito-
chondrial bodies was observed after berberine treatment,
although determination of mitochondrial mass by EM war-
rants several notes of caution. By comparing Fig. 5, A with B,
it is also observable that loss of mitochondrial TMRM fluo-
rescence accompanies fragmentation even for 6 h of exposure
(Fig. 5, I and J). Berberine (50 M) was used to investigate
whether a dose-dependent effect could be found. In fact, the
depolarization effect obtained with the higher concentration
was not dissimilar from the result obtained with the lower
concentration. Figure 5F shows control condensed mitochon-
dria where cristae can be easily observed. In contrast, most
mitochondrial bodies lost their typical shape, swelled, and
appeared to lose their cristae after a 24-h incubation period
with berberine, although different degrees of damage were
observable (Fig. 5, D–H). The apparent decrease in mitochon-
drial numbers by electron microscopy was also supported by
the finding that mtDNA copy number decreases when cells
are treated with 25 M berberine for 24 and 48 h (Fig. 5K).
Surprisingly, when that maximum berberine concentration
used in proliferation studies (100 M) was used, no decrease
in mtDNA copy number occurred. The normal processes that
occur in an apoptotic cell, such as nucleus/chromatin conden-
sation, membrane blebbing, and the formation of apoptotic
bodies, was not observed at the concentrations of berberine
used in this study (up to 100 M; data not shown).
Berberine Increases Intracellular Oxidative Stress.
To test whether berberine increases oxidative stress, cells
were incubated with the drug (25 M) for 6 and 24 h. Forty-
five minutes before the end of incubation period, cells were
incubated with Hoechst 33342, TMRM, and CM-H2DCFDA,
a fluorescent probe for oxidative stress. Figure 6 shows that
6 h of exposure is not enough to cause a significant increase
in intracellular oxidative stress as opposed to 24 h of drug
exposure when an increase of probe fluorescence was ob-
served in cells treated with 25 M berberine. We also con-
firmed that the mitochondrial depolarization precedes the
detection of oxidative stress.
Berberine Decreases Energy Charge in K1735-M2
Cells. Berberine decreases cellular energy charge, ([ATP] 
0.5 [ADP])/([ATP]  [ADP]  [AMP]), with the greatest de-
creases occurring after 72 h (Table 1). The ratio of ATP/ADP
was also altered by berberine when cells were incubated for
24 h (Table 1). Interestingly, for longer exposure periods, the
effects of berberine on the ATP/ADP ratio are decreased. In
fact, for 72 h, the ratio is not dissimilar from the control.
Regarding the specific type of adenine nucleotide affected by
berberine, the results (Table 2) demonstrate that ATP quan-
tity decreases within 24 h in the presence of 25 Mberberine.
As opposed to the unchanged ATP/ADP ratio found for 72 h,
there is a statistically significant change in ATP concentra-
tion between control and treated cells. The unchanged ratio
described in Table 1 is caused by the simultaneous decrease
of ADP, which is also accompanied by increased AMP levels.
The overall results indicate that both ATP and ADP are
decreased by berberine treatment, whereas AMP concentra-
tions increase. FCCP, a mitochondrial uncoupler, shows sim-
ilar results to that of berberine, suggesting a possible equiv-
alence of targets and mechanisms of action. None of the
drugs or concentrations tested altered the total number of
adenine nucleotides.
Berberine Affects Mitochondrial Oxygen Consump-
tion. The effect of berberine on mitochondrial oxygen con-
sumption with both glutamate/malate and succinate as sub-
strates is described in Tables 3 and 4, respectively. Under the
range of concentration of up to 66.7 nmol berberine/mg pro-
tein, berberine decreases the respiratory control ratio (RCR)
for both respiratory substrates (absolute values of control,
6.0 0.67 for glutamate/malate and 4.1 0.43 for succinate).
However, the decrease is more evident when the substrate
for complex I is used (approximately 80 versus 50% when
succinate is used at the highest berberine concentration).
The ADP/O ratio remained unchanged for both types of sub-
strate except for the higher concentrations (33.35 and 66.7
nmol berberine/mg protein), where a significant decrease can
be observed (absolute values of control, 2.2  0.21 for gluta-
mate/malate and 1.6  0.15 for succinate). The results sug-
gest an effect on the electron transfer chain (predominantly
at the complex I level) but also a possible interference in the
mitochondrial phosphorylation system. The values for the
RCR of the control group denote a good mitochondrial prep-
aration, which is further confirmed by the ADP/O values. In
the presence of the uncoupler FCCP, respiration is progres-
sively decreased by berberine regardless of the drug concen-
tration or respiratory substrate. However, it must be stressed
that mitochondrial respiratory state 3 is more strongly in-
hibited compared with uncoupled respiration when mito-
chondria are energized by complex I substrates as observed
in Fig. 7A. When liver mitochondria were energized with a
complex II substrate, respiratory state 3 decreased in a sim-
ilar fashion to uncoupled respiration. When glutamate/
malate is used, mitochondrial respiratory state 4 is not al-
tered except for the highest berberine concentration used
(100 M). When mitochondria are energized by succinate, an
increase of oxygen consumption in mitochondrial respiratory
state 4 is observed instead, but this effect is abolished when
oligomycin is added, suggesting a possible increased passive
flux of protons through the FO subunit of the ATP synthase.
Stimulation of respiration during state 4 is not observed
when mitochondria are energized by glutamate/malate be-
cause more severe inhibition of the respiratory chain may
hide the effect.
Berberine Affects the Generation of Mitochondrial
Membrane Potential. When analyzing the effects of ber-
berine on mitochondrial  generation (Tables 5 and 6; Fig.
8), only the highest concentrations have significant effects on
the maximal  generated. The differences are more drastic
when parameters related to the phosphorylation system are
analyzed, namely the depolarization induced by ADP and the
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Fig. 5. Mitochondrial alterations induced
by berberine. The effects of berberine on
mitochondrial structure were evaluated by
using confocal and electron microscopy.
MtDNA copy numbers were evaluated by
using real-time PCR. A and B, confocal mi-
croscopy of K1735-M2 cells treated with ve-
hicle (A) and 25 M berberine (B) during
24 h. White bar, 15 m. Live cells were
labeled with the fluorescent probes TMRM
(mitochondria) and Hoechst 33342 (nuclei)
for 30 min before observation with a confo-
cal microscope. C, detail of a cell treated
with 25 M berberine during 24 h, where
fragmented and round mitochondria la-
beled with TMRM can be observed. Hoechst
33342 (nucleus) and calcein-AM (cyto-
plasm) were the two other probes used. Cy-
toplasmic calcein granules are also observ-
able, although their origin has yet to be
identified. D and E, electron microscopy
(white bars, 5 m) showing K1735-M2 cells
treated with vehicle (D) and 25 M berber-
ine (E) during 24 h. White arrow, mitochon-
drial bodies. F to H, electron microscopy
showing K1735-M2 cells treated with vehi-
cle (F), 10 M (G), and 25 M berberine (H)
during 24 h. White arrow, mitochondrial
bodies. All three panels are the same mag-
nification. I and J, evaluation of TMRM
fluorescence in cells treated with vehicle
and 25 and 50 M berberine for 6 (I) and 24
(J) h. Quantification of cell fluorescence
was made as described underMaterials and
Methods. , p  0.05 versus control. K,
mtDNA copy number of cells treated with
vehicle or 25 or 100 M berberine. Relative
mtDNA copy numbers were determined as
described under Materials and Methods.
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phosphorylation lag phase. The effects are observable for
both substrates. It should be noted that for higher drug
concentrations, mitochondria do not recover their normal 
values after ADP addition. The results again suggest that the
effects of berberine on isolated mitochondrial fractions are
most evident when mitochondria are challenged to increase
their respiration rate, either by using ADP or FCCP.
Berberine Stimulates the MPT on Isolated Rat Liver
Mitochondria. One of the effects of MPT pore opening is
mitochondrial swelling due to osmotic equilibrium between
the matrix and the external compartment, leading to water
influx. The effect of berberine on Ca2/phosphate-induced
mitochondrial swelling was studied by measuring the
changes in the suspension absorbance at 540 nm in a sucrose-
based media. Figure 9 shows that berberine in a range up to
133.2 nmol/mg protein increases swelling of isolated liver
mitochondria in the presence of 20 M calcium. Surprisingly,
the mitochondrial swelling rate augmented by berberine does
not appear to be dose-dependent because at higher concen-
trations, swelling slows without a decrease in amplitude
(Table 7). These results were confirmed by oxygen consump-
tion when calcium was added to mitochondria energized with
succinate (data not shown)., The MPT pore inhibitor CsA
(Broekemeier et al., 1989) was able to prevent mitochondrial
swelling in the presence of berberine, confirming that this
effect is caused by the induction of the MPT pore.
Berberine Decreases Mitochondrial Calcium Load-
ing Capacity. To confirm that berberine induces MPT pore
opening, we evaluated mitochondrial calcium loading capac-
ity in the presence of this alkaloid. Extramitochondrial cal-
cium levels were followed by using the fluorescence probe
Calcium Green 5N. Shortly after an increase in probe fluo-
rescence due to calcium addition, fluorescence decreased in
all conditions tested, indicating mitochondrial calcium up-
take. However, berberine, in a dose-dependent fashion (Fig.
10, lines 1–3), decreased calcium accumulation compared
with controls. When mitochondria were preincubated with
CsA, calcium-induced calcium release in the presence of ber-
berine was inhibited. The data confirm that berberine de-
creases mitochondrial calcium loading capacity through in-
creased MPT pore induction.
Berberine Increases Reactive Oxygen Species Produc-
tion on Isolated Mitochondria. To determine whether the
increase in oxidative stress observed in berberine-treated cells
Fig. 6. Berberine induced mitochondrial
depolarization and increased oxidative
stress in K1735-M2 mouse melanoma
cells. Cells were incubated with 25 M
berberine for 6 or 24 h. Forty-five minutes
before the end of the incubation period,
the fluorescent probes TMRM (red, mito-
chondria), Hoechst 33342 (blue, nuclei),
and CM-H2DCFDA (green, oxidative
stress) were incubated with cells and im-
aged with a Nikon Eclipse 3000 epifluo-
rescence microscope.
TABLE 1
Effects of berberine in the energy charge and ATP/ADP ratio in K1735-M2 mouse melanoma cells
FCCP, a mitochondrial uncoupler, was added as a positive control. Energy charge was calculated as (ATP	  0.5 ADP	)/(ATP	  ADP	  AMP	). Data are means S.E.M.
of at least four different preparations.
Control
Berberine
FCCP (10 M)
10 M 25 M 50 M 100 M
Energy charge
24 h 0.41  0.03 0.33  0.03 0.30  0.03 0.27  0.05* 0.23  0.04* 0.25  0.03*
48 h 0.50  0.04 0.40  0.04 0.33  0.03* 0.27  0.04* 0.25  0.04* 0.28  0.03*
72 h 0.52  0.06 0.27  0.04* 0.23  0.03* 0.22  0.04* 0.25  0.03* 0.30  0.04*
ATP/ADP
24 h 1.43  0.26 0.88  0.13* 0.76  0.10* 0.63  0.04* 0.64  0.07* 0.80  0.06*
48 h 1.50  0.15 1.28  0.11 1.11  0.12 0.96  0.04* 0.93  0.13* 1.18  0.10
72 h 1.58  0.18 1.41  0.14 0.98  0.13 1.27  0.28 1.16  0.15 1.03  0.22
* p  0.05 vs. control for each time of incubation.
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also occurs in isolated mitochondrial fractions, intramitochon-
drial oxidative stress was measured using the fluorescent probe
CM-H2DCFDA. To pinpoint a possible source of increased oxi-
dative stress in the respiratory chain, we used different sub-
strates and a specific complex I inhibitor (rotenone, 1.5 M). As
demonstrated in Fig. 11, there were no significant differences
compared with the control except for the lowest berberine con-
centration (6.7 nmol/mg). When using glutamate-malate as
substrate and in the absence of rotenone, probe oxidation was
higher in the presence of 6.7 nmol berberine/mg protein com-
pared with the control. The fluorescence of the probe (due to
oxidation) decreased when rotenone was added to the system.
No differences were observed when succinate in the presence of
rotenone was used, regardless of the berberine concentration
used. The observation leads us to assume that reactive oxygen
species production can be localized downstream to the rotenone
binding site on complex I.
Berberine Does Not Affect ATPase Activity. The dif-
ferences observed in the ADP/O parameter, along with ber-
berine-induced differences in ADP depolarization and phos-
TABLE 2
Effects of berberine on adenine nucleotides levels of K1735-M2 mouse melanoma cells
Cells (1.0 105) were treated with berberine in a range up to 100 Mat different incubation times. FCCP, a mitochondrial uncoupler, was added as a positive control. Adenine
nucleotides quantification was realized as described under Materials and Methods, and data are described as percentage of total nucleotides. Data are means  S.E.M. of
at least four different preparations.
Control
Berberine
FCCP (10 M)
10 M 25 M 50 M 100 M
Total nucleotides (pmol/mg protein)
24 h 1343.8  268.1 1731.4  207.1 2001.1  249.6 2184.0  377.1 1834.9  460.1 2059.3  225.7
48 h 1813.4  131.7 2369.6  212.2 1730.0  277.6 1828.4  454.3 151.47  140.7 1640.4  273.3
72 h 1275.2  312.1 1838.1  466.5 1469.6  433.0 1539.1  469.2 2127.4  393.6 1632.3  250
ATP (%)
24 h 30.2  2.8 20.8  3.1 18.2  2.8* 15.3  3.1* 13.8  2.1* 15.8  2.4*
48 h 38.3  3.8 28.0  3.6 21.5  3.3* 17.2  2.7* 15.8  3.4* 18.8  2.6*
72 h 39.0  5.6 20.0*  3.0 18.74  3.4* 18.2  3.9* 18.3  3.4* 20.1  3.4*
ADP (%)
24 h 25.0  2.9 24.1  1.3 23.9  1.5 23.7  3.3 21.3  3.2 19.3  1.7
48 h 26.9  1.3 24.6  1.5 22.3  2.2 20.3  2.5 18.2  1.6* 18.1  2.1*
72 h 25.2  2.5 14.5  2.5* 9.1  2.4* 8.4  1.6* 12.6  1.5* 20.8  2.5
AMP (%)
24 h 47.5  3.7 55.0  3.3 57.9  3.8 61.0  6.4 67.9  5.4* 65.0  4.0
48 h 36.8  3.7 47.4  4.0 56.2  4.5* 62.4  4.7* 65.9  4.6* 63.2  4.0*
72 h 43.0  1.68 65.5  5.3* 73.6  3.4* 73.4  3.7* 69.2  3.1* 59.1  5.0
* p  0.05 vs. control for each incubation time.
TABLE 3
Effects of berberine on mitochondrial respiratory parameters energized by glutamate/malate
Data represent percentage control. Mitochondria (1.5 mg) were incubated in 1 ml of respiration media (see Materials and Methods) at 30°C. State 4 was measured in the
presence of 5 mM glutamate plus malate. ADP (125 nmol) was added to induce state 3 respiration. Oligomycin (1 g) and FCCP (1 M) were also added to the system to inhibit
passive flux through the ATP synthase and to uncouple respiration. The RCR was calculated as the ratio between state 3 and state 4 respiration. The ADP/O was calculated
as the number of nanomoles of ADP phosphorylated by nanoatoms of oxygen consumed during ADP phosphorylation. Data are means  S.E.M. of four to five different
preparations. Control absolute values are expressed as nanoatoms of oxygen per minute per milligram of protein. Other values are expressed as percent control values; n.m.,
not measurable.
Berberine Control 6.7 nmol/mgProtein
16.7 nmol/mg
Protein
33.4 nmol/mg
Protein
66.7 nmol/mg
Protein
%
State 3 59.3  3.8 83.2  3.0 57.8  6.6* 33.4  4.8 * 14.7  4.7*
State 4 12.8  0.6 107.0  9.0 99.0  13.7 105.3  14.6 47.6  7.5*
RCR 6.0  2.1 76.3  6.3* 66.0  7.2* 30.0  6.2 * 22.9  5.9*
ADP/O 2.2  0.7 96.4  9.2 93.3  3.3 n.m. n.m.
Oligomycin 7.4  3.0 111.6  9.3 78.5  16.2 79.2  13.7 65.3  5.8
FCCP 68.2  6.7 83.8  4.1 73.9  5.2* 61.8  6.49* 56.4  11.4*
* p  0.05 vs. control.
TABLE 4
Effects of berberine on mitochondrial respiratory parameters energized by succinate
Data represent percentage against control. Experiences were carried out in the same conditions as describe in Table 3 but with mitochondria energized with 5 mM succinate
in the presence of 3 M rotenone. Data are means  S.E.M. of four to five different preparations. Control absolute values are expressed as nanoatoms of oxygen per minute
per milligram of protein. Other values are expressed as percent control values.
Berberine Control 6.7 nmol/mgProtein
16.7 nmol/mg
Protein
33.4 nmol/mg
Protein
66.7 nmol/mg
Protein
%
State 3 90.7  10.2 90.8  5.6 75.8  1.8* 74.6  3.6* 58.6  4.7*
State 4 22.6  1.6 96.4  5.7 110.8  8.1 127.7  3.2* 143.0  8.8*
RCR 4.1  0.4 93.8  4.1 69.1  4.4* 62.4  7.0* 44.9  4.9*
ADP/O 1.6  0.2 91.8  3.0 94.1  3.0 83.5  1.3* 81.4  3.2*
Oligomycin 16.4  2.1 94.5  3.5 105.9  4.7 113.8  6.2 108.9  9.4
FCCP 152.7  16.2 85.8  4.1 79.7  3.9* 70.6  7.2* 52.0  4.4*
* p  0.05 vs. control.
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phorylation lag phase as obtained by using a TPP-selective
electrode, suggested that this alkaloid may have a negative
effect on mitochondrial ATP synthase (complex V). To test
this possibility, ATPase activity experiments were per-
formed. By using two distinct methods, no statistically sig-
nificant differences were observed between control and ber-
berine-treated mitochondria (Table 8), indicating that
berberine apparently does not inhibit complex V activity.
Discussion
Medicinal herbs have been used for millennia to treat or
prevent several maladies such as cancer (Dorai and Aggar-
wal, 2004). Since most active compounds responsible for the
pharmacological effect are still unknown, the literature is
rich in research involving purification of the active compo-
nents and evaluation of their pharmacological use. An impor-
Fig. 7. Typical recording of the effect of berberine on mitochondrial oxygen consumption. Mitochondria (1.5 mg) were incubated in 1 ml of standard
reaction media as described underMaterials and Methods. Respiration was started by adding 5 mM glutamate plus malate (A) or 5 mM succinate with
3 M rotenone (B). ADP (125 nmol) was added to initiate state 3. Oligomycin (1 g) and FCCP (1 M) were also added to the system to inhibit passive
flux through the ATP synthase and to uncouple respiration, respectively. Berberine, 6.67 nmol/mg (2), 16.68 (3), 33.35 (4), and 66.7 (5), was
preincubated during 2 min. Line 1, control situation.
TABLE 5
Effects of berberine on glutamate/malate-energized mitochondria.   max., ADP depolarization, and lag phase were measured by using a TPP-
selective electrode (for further details of the method, see Materials and Methods). The values present are mean  S.E.M. n.m., not measurable.
  max. ADP Depolarization Lag Phase

mV s
Control 215.2  5.4 (100%) 27.5  1.8 (100%) 24.0  2.1 (100%)
Berberine
6.7 nmol/mg protein 216.5  2.9 (100.9  2.6%) 28.4  1.5 (105.6  9.4%) 30.5  4.8 (124.1  9.6%)
16.7 nmol/mg protein 217.7  3.6 (101.4  2.6%) 26.5  1.6* (98.6  8.9%) 35.8  5.9 (144.6  12.1%)
33.4 nmol/mg protein 215.9  4.9 (100.7  17.0%) 24.5  1.6* (76.2  16.5%) 47.1  8.6* (171.0  40.8%)
66.7 nmol/mg protein 212.7  5.2* (99.1  2.9%) 34.6  5.7 (131.6  21.5%) n.m.
* p  0.05 vs. control.
TABLE 6
Effects of berberine on succinate-energized mitochondria
  max, ADP depolarization, and lag phase were measured by using a TPP-selective electrode (see Materials and Methods). The values presented represent means 
S.E.M.
  Max ADP Depolarization Lag Phase

mV s
Control 214.3  5.8 (100%) 33.5  2.5 (100%) 21.2  1.4 (100%)
Berberine
6.7 nmol/mg protein 214.0  3.2 (99.8  2.9%) 28.4  1.0* (88.0  9.6%) 25.8  1.9(122.9  10.2%)
16.7 nmol/mg protein 212.7  3.5 (99.6  3.0%) 24.1  1.3* (74.8  8.9%) 29.2  2.7 (139.5  13.9%)
33.4 nmol/mg protein 209.9  4.0* (98.2  3.1%) 17.9  1.7* (55.8  8.2%) 37.2  4.1* (178.1  21.0%)
66.7 nmol/mg protein 206.2  4.1* (96.5  3.0%) 11.3  2.0* (35.6  7.1%) 45.6  3.0* (179.2  37.1%)
* p  0.05 vs. control.
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tant aspect is to investigate the toxic effects of phytochemi-
cals found in traditional medicine on biological systems
because many formulations may be found in over-the-counter
medications.
In the present work, we demonstrate that berberine inhib-
its the proliferation of K1375-M2 mouse melanoma cells.
Although we did not specifically measure the contributions of
cell death and/or cell cycle arrest, it appears that concentra-
tions of berberine up to 100 Mdo not cause significant levels
of death in these cells. By morphological analysis, no typical
alterations characteristic of apoptosis or necrosis were found
(Serafim et al., 2007). Therefore, the inhibition of prolifera-
tion (Fig. 2) results from cell cycle arrest instead of cell death.
Our data contrast with works from other laboratories (Kuo et
al., 1995; Hwang et al., 2006; Letasiova et al., 2006; Lin et al.,
2006; Mantena et al., 2006b), where berberine was found to
promote apoptosis. However, many of these studies used
concentrations of berberine much higher than those used
here. In addition, different cell lines have been show to ex-
hibit significantly different sensitivities to apoptotic induc-
tion by berberine (Letasiova et al., 2006).
The advantages of the fluorescence properties of berberine
were used to demonstrate that the drug primarily accumu-
lates in mitochondria. These results are in agreement with
previous studies (Serafim et al., 2007) where we demon-
strated that berberine is accumulated primarily in mitochon-
dria at lower concentrations (up to approximately 50 M) but
becomes detectable in the nucleus and cytoplasm at higher
concentrations (over 50 M), possibly due to saturation of the
Fig. 8. Representative recording of mitochondrial electric potential measured with a TPP-selective electrode. Rat liver mitochondria (1.5 mg) were
incubated in 1 ml of the medium supplemented with 3 M TPP. Energization of the mitochondrial population was achieved with 10 mM
glutamate-malate (A) or 10 mM succinate plus 3 M rotenone (B). After stabilization of the recording, 125 nmol ADP was added. For more details,
see Materials and Methods. Line 2, lowest berberine concentration tested (6.67 nmol/mg protein); line 3, the highest concentration tested (66.7
nmol/mg protein). Line 1, control situation.
Fig. 9. Typical recording of the effect of berberine on Ca2/-induced
mitochondrial swelling evaluated by the decrease of optical density at 540
nm caused by calcium. Mitochondria (1.5 mg) were energized by succi-
nate. After a basal line was established, 20 M calcium was added to
induce the MPT pore. Berberine was incubated with mitochondria in the
following amounts (in nanomoles per milligram of protein): 13.3 (3), 33.3
(4), 66.6 (5), 100.0 (6), and 133.2 (7). Line 2, control situation. Cyclosporin
A was preincubated before the addition of calcium and was able to
prevent mitochondrial swelling (1). The recordings showed here are rep-
resentative of at least four different separated mitochondrial prepara-
tions.
TABLE 7
Effects of different berberine concentrations (numbers in the left
column) on Ca2/phosphate-induced mitochondrial swelling parameters
studied by measuring absorbance changes in the suspension in a
sucrose-based media
Swelling amplitude was calculated as the difference between basal line absorbance
and the absorbance after 500 s. Rate values represent the initial mitochondrial
swelling rate after the addition of calcium. Data are means  S.E.M. of at least four
different experiments.
Amplitude Swelling Rate
arbitrary units arbitrary units/min
Ca2 alone 
0.465  0.182 
0.045  0.041
Ca2  13.3 nmol/
mg protein

1.147  0.084* 
0.277  0.041
Ca2  33.3 nmol/
mg protein

1.198  0.059* 
0.505  0.065*
Ca2  66.6 nmol/
mg protein

1.295  0.050* 
0.472  0.100*
Ca2  100 nmol/
mg protein

1.045  0.237* 
0.367  0.142*
Ca2  133.2 nmol/
mg protein

1.281  0.119* 
0.346  0.035
Ca2  133.2 nmol/
mg protein  CsA

0.241  0.159† 
0.047  0.036†
* p  0.05 vs. control.
† p  0.05 vs. Ca 2  133.2 nmol berberine/mg protein.
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mitochondrial compartment. Berberine is a positively
charged isoquinolinium molecule; such compounds are more
active inhibitors of the mitochondrial respiratory chain than
uncharged molecules when tested on isolated mitochondria
(Barreto et al., 2003), which may reflect a stronger affinity for
the negatively charged matrix. Likewise, we demonstrate
that the mitochondrial electric transmembrane potential is a
driving force for drug accumulation because FCCP prevents
mitochondrial berberine fluorescence. Mikes and Dadak
(1983) presented similar results, although an increase in
berberine fluorescence quantum yield upon mitochondrial
energization was suggested as the explanation (Mikes and
Dadak, 1983). One crucial piece of data from our results is
the appearance of berberine fluorescence in nuclei or cyto-
plasm after incubation of cells with FCCP and berberine
concentrations that do not normally stain nuclei and cyto-
plasm. One would expect that if mitochondrial-localized ber-
berine was mostly losing its fluorescence quantum yield upon
FCCP treatment, then nuclei and cytoplasm should not
change their fluorescence characteristics. The primary accu-
mulation in mitochondria versus other cell compartments
can also help explain the effect of the compound in promoting
cell cycle arrest versus cell death. In fact, certain other pos-
itively charged isoquinolines are primarily accumulated in
the nucleus and act through promoting cell death (e.g., san-
guinarine; J. Matos and P. J. Oliveira, unpublished data)
with few alterations in mitochondrial bioenergetics (Barreto
et al., 2003).
Mitochondria are well known to produce free radicals as a
consequence of mitochondrial respiration (Sastre et al.,
2000). Assays with dichlorofluorescein, a probe whose fluo-
rescence increase in the presence of oxidants, show that
berberine increases oxidative stress in K1735-M2 cells. To
clarify whether increased oxidative stress results from mito-
chondrial interactions, experiments on isolated mitochondria
were conducted. Results show that berberine, for the lowest
concentration tested, increases oxidative stress on isolated
liver mitochondria when using complex I substrates, which
may help explain results in intact cells exposed to berberine.
Increased oxidative stress can be attributed to an interaction
of berberine at a site downstream of the rotenone binding site
because this inhibitor inhibits berberine-induced oxidative
stress. Even without using alternative inhibitors of the re-
spiratory chain, it is likely that the site is located on complex
I because berberine does not produce significant oxidative
Fig. 10. Assessment of mitochondrial
calcium loading capacity in the pres-
ence of berberine. Berberine was incu-
bated with mitochondria (0.4 mg) in
the following amounts: 1, 31.2 nmol/
mg; 2, 15.6 nmol/mg; 3, 6.2 nmol/mg;
and 5, 31.2 nmol/mg berberine in the
presence of cyclosporin A (100 nM).
Line 4, control situation. The fluores-
cent probe Calcium Green 5-N (100
nM) was used to evaluate the levels of
extramitochondrial calcium as de-
scribed under Materials and Methods.
Fig. 11. Evaluation of intramitochondrial reactive oxygen species pro-
duction by using the fluorescent probe CM-H2DCFDA. Mitochondria (1
mg) were incubated in 2 ml of the standard reaction media (250 mM
sucrose and 10 mM HEPES-KOH, pH 7.4) as described under Materials
and Methods. After predetermined time intervals, rotenone (1.5 M) and
succinate (2.5 mM) were added to the system. The graphic shows the
variation of fluorescence rate relative to the control condition. White bars,
glutamate/malate; gray bars, glutamate/malate in the presence of rote-
none; black bars, succinate. , p  0.05 versus respective control.
TABLE 8
Measurement of ATPase activity using two distinct methods: in the
first column, the detection of pH changes associated with ATP
hydrolysis was measured with a pH electrode (see Materials and
Methods); in the second method tested,  generated by ATP
hydrolysis was measured by using a TPP-selective electrode
Values are means  S.E.M. of three different mitochondrial preparations.
nmol H/
mg Protein   (
mV)
Control 3.6  0.2 166.8  2.0
33.4 nmol Berberine/mg protein 3.9  0.2 166.6  1.6
66.7 nmol Berberine/mg protein 4.1  0.4 167.7  1.4
* p  0.05 vs. control.
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stress in rotenone-treated mitochondria energized with suc-
cinate. These actions resemble those of doxorubicin, an an-
thracycline used in anticancer therapy that generates oxida-
tive stress at mitochondrial complex I (Berthiaume and
Wallace, 2007). As described, increased oxidative stress oc-
curs only for the lowest berberine concentrations, which can
be explained by a report demonstrating that berberine pos-
sesses antioxidant properties (Hwang et al., 2002). It is pos-
sible that at lower concentrations, pro-oxidant actions
through inhibition of Complex I outweigh the antioxidant
activity of berberine, whereas at higher concentrations, the
antioxidant activity prevails over the pro-oxidant effects.
It is reasonable to think that berberine, once accumulated
within the mitochondria, affects oxidative phosphorylation
efficiency and compromises the normal behavior of the cell.
The decrease in cell ATP concentration observed after ber-
berine treatment can explain the cell cycle arrest because
ATP has been described to regulate the cell cycle (Gemin et
al., 2005).
When comparing standard respiratory parameters in iso-
lated rat liver mitochondria, berberine inhibition of oxygen
consumption is more pronounced when respiratory sub-
strates for complex I are used. Barreto et al. (2003) have also
demonstrated that berberine affects more the activity of the
isolated NADH dehydrogenase (complex I) compared with
the isolated succinate dehydrogenase (complex II). Mikes et
al. (Mikes and Dadak, 1983; Mikes and Yaguzhinskij, 1985)
also observed that berberine derivatives have a predominant
effect on mitochondrial complex I. The results from the
present study indicate that although berberine appears to
have a predominant effect when complex I substrates are
used, succinate-sustained respiration is also inhibited, sug-
gesting a broader range of targets in the respiratory chain.
The analysis of ADP/O, ADP depolarization, and lag phase
also suggest that berberine interacts with the mitochondrial
phosphorylative system. One of the constituents of the phos-
phorylative system is the ATP synthase, which is responsible
for the production of ATP. Two distinct experiments show
that berberine does not affect complex V activity. However,
there are other constituents of the phosphorylative system
such as the adenine nucleotide transporter or the phosphate
uniporter that can also be possible targets for berberine
action. In fact, one attractive candidate is the adenine nucle-
otide translocator because it is also a component of the MPT
pore (see below). Work is currently underway to clarify this
question. The effects of berberine on isolated mitochondria
can explain the decrease in energy status observed in intact
cells treated with this alkaloid.
The presence of berberine in mitochondria seems to in-
crease the susceptibility to MPT pore opening since swelling
amplitude is increased when berberine is added. Results
obtained using a fluorescent calcium probe confirmed the
swelling results, indicating that berberine decreases mito-
chondrial calcium loading capacity through increased induc-
tion of the MPT pore. Interestingly, electron microscopy
shows that most mitochondria from berberine-treated cells
are swollen, pale, and lack identifiable cristae, suggesting
that they have undergone the MPT. MPT pore opening in
intact cells is still a controversial topic because several cyto-
solic factors may alter MPT pore gating properties. However,
the occurrence of the MPT pore induced by berberine is a
possible explanation to the decreased number of mitochon-
drial bodies and swollen aspect of most mitochondria.
Although normal liver and cancer cell mitochondria may
present certain structural and functional differences, we be-
lieve that sufficient similarities exist to justify using isolated
liver mitochondria as models to gain insights into the actions
of xenobiotic compounds with the mitochondrial system of
malignant cells. In addition, isolated fractions present the
advantage of a much higher isolation yield so that more
aspects of mitochondrial function can be studied with one
single isolation procedure.
Two observations from this work deserve future attention.
First, we have observed that berberine enhances the calcium-
induced permeability transition in isolated liver mitochon-
drial fractions, at least from morphological data, apparently
as well in intact cells. We tried to use cyclosporin A to test the
possibility that berberine also stimulates the MPT in intact
cells, but berberine effects were actually exacerbated (data
not shown), which can be attributed to inhibition of berberine
efflux by cyclosporin A (Sonneveld and Wiemer, 1997). It is
interesting that the enhanced MPT occurrence in intact cells,
if confirmed, did not result in K1735-M2 cell death, although
it is reasonable to speculate that the decrease in mitochon-
drial mass may be related to mitochondrial destruction in-
duced by the MPT. The second interesting observation deals
with the decrease of mtDNA copy number for 25 but not for
100 M. Berberine is known to intercalate into double-
stranded DNA, forming adducts that can inhibit DNA repli-
cation (Kuo et al., 1995), which could explain the reduced
mtDNA copy numbers in cells treated with low concentra-
tions of berberine. It is possible that the lack of reduction in
mtDNA copy number in cells treated with 100 M berberine
reflects a compensatory mechanism that attempts to over-
come the decreased mitochondrial ATP production by in-
creased mtDNA copy number. Alternatively, it could be that
the higher levels of oxidative stress induced by lower concen-
trations of berberine result in mtDNA destruction that is
either blocked by the antioxidant effects of higher concentra-
tions of berberine or somehow inhibited by a “protective”
effect of a larger quantity of intercalated berberine. It would
be of interest to obtain and compare accurate measures of
mitochondrial mass with mtDNA quantity in cells treated
with different concentrations of berberine.
During several cell events (including apoptosis), mitochon-
drial fragmentation is observed, which results in smaller,
rounder, and more numerous mitochondria (Arnoult, 2007).
The results from epifluorescence microscopy show that the
mitochondrial network is dissipated after berberine treat-
ment, but the number of mitochondria does not increase as
shown by EM. A possible explanation is that the fragmented
mitochondria are damaged and end up being destroyed. The
results demonstrate that the mitochondrial network is
strongly affected by berberine, but the cause is not immedi-
ately clear. It has been demonstrated that oxidative stress
causes mitochondrial fragmentation (Sarda˜o et al., 2007),
and the increased oxidative stress observed after treatment
with low doses of berberine could explain the vesiculation of
the mitochondrial network observed by epifluorescence mi-
croscopy. Unfortunately, the extensive mitochondrial depo-
larization induced by high concentrations of berberine makes
observation of mitochondrial morphology with charge-depen-
dent probes like TMRM difficult.
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The present work shows that berberine is accumulated by
mitochondria of a mouse melanoma cell line, leading to mi-
tochondrial fragmentation and dysfunction, accompanied by
decreased cellular energy charge. When the effect was com-
pared with the results obtained on isolated mitochondrial
fractions, it is observed that regardless of the system used,
berberine is toxic for mitochondria. One major limitation of
the present study (as in many others) is the lack of knowledge
of the real concentration of berberine that reaches mitochon-
dria in intact cells. Although we do not possess data regard-
ing this aspect, it is wise to speculate that mitochondrial
berberine concentrations will be much higher than in the
bulk cytosol due to electrophoretic accumulation. We believe
that the range of berberine concentrations accumulated by
mitochondria in intact cells is within the range of concentra-
tions used on isolated mitochondrial fractions in the present
study. The present work not only provides insights on the
mechanism by which berberine interferes with tumor cell
proliferation, demonstrating previously unknown effects on
mitochondrial physiology, but also raises a note of caution on
the use of berberine as a nontoxic “natural” over-the-counter
medication.
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